Determination of neuron specific enolase (NSE) in small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) patients

Journal Title: Pakistan Journal of Pharmacology - Year 2011, Vol 28, Issue 1

Abstract

Neuron specific enolase (NSE) is routinely used as tumor marker in Small cell lung carcinoma (SCLC), and to some extent in non-small cell lung carcinoma (NSCLC). In Pakistan, tumor marker technology is not a new one. It is however mostly directed towards uses in hepatic, breast, ovarian, uterine and colorectal cancers, whereas availability and general practice of its use for diagnosis of respiratory metastasizing disease such as lung cancer is seldom and rare, especially the SCLC/NSCLC specific NSE. The aim of present study is to determine the potential usefulness of NSE in diagnosis and prognosis of SCLC and NSCLC patients in our setting. Fifty-eight patients of lung cancer were identified and selected, between January 2004 to December 2007, and divided into various groups depending upon their clinical stage of disease. NSE level was determined in all patients and clinical history data and related pathophysiolgical components of all selected patients were carefully assessed and compulsorily followed to avoid any bias. Cancer status of patients were evaluated by data available from multiple bronchoscopies, X rays, cytology and histopathology examinations and grouped as SCLC with all five stages (I, II, IIIA, IIIB and IV) and NSCLC with only stage IV. NSE level was also determined in Healthy subjects and patients with non-malignant lung diseases (NMLD) for comparison. We observed significant elevation in levels of NSE for different stages of SCLC and NSCLC in comparison with healthy and NMLD groups. Most significant increase was noted in SCLC stage IV not only in comparison with healthy (P < 0.001) and NMLD groups (P < 0.001) but also with stage I (P < 0.001) within the group. Elevated difference in NSE levels was also correlated with stage II, IIIA and IIIB. However, no significant difference in levels was established among Stage II, III A and IIIB of SCLC group. As regard NSCLC, where patients belonged only to stage IV of disease, significant difference was observed with healthy (P < 0.001) and NMLD (P < 0.001) groups. Comparison among SCLC and NSCLC groups revealed significant difference of NSE levels in stage I (P < 0.01) and stage IV (P < 0.01) when compared with NSCLC, whereas non-significant difference in NSE levels was noted in group-SCLC stage II, IIIA and IIIB. In comparison, all stage IV patients (n = 7) of SCLC exhibited higher levels of NSE with a range of 136.19 ng/ml to 175.01 ng/ml, higher than detected in patents of stage IV in NSCLC. The result of our study suggests that NSE appears to be a useful tumor marker for SCLC and to some extent, NSCLC. Moreover, NSE exhibits higher levels in some stages of SCLC suggesting, its specificity, not only for advanced stage of SCLC but also for SCLC in general as compared to NSCLC. Its determination, therefore, is beneficial in the diagnosis, treatment and a possible follow-up for patients’ survival.

Authors and Affiliations

Syed Mahmood, Junaid Alam, Amna Hussain

Keywords

Related Articles

Analgesic, antimicrobial and cytotoxic effect of Cyperus rotundus ethanol extract

In present study preliminary screening was carried on Cyperus routunds crude extract which showed the presence of tannins, sapanins, carbohydrate in colour reaction method while the alkaloids, protein and sterol were abs...

Hypoglycemic and hypocholesterolemic effects of Acacia tortilis (fabaceae) growing in Makkah

Traditional use of herbs and plants is centuries old and they have shown therapeutic properties. But scientific studies are not done to confirm their efficacy and margin of safety. Acacia was collected from UQU, Makkah....

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A qualitative review

Obsessive-compulsive disorder (OCD) is a relatively common disorder, most of the time under diagnosed and under treated despite the existence of effective treatments. OCD can be discriminated from other disorders, having...

Incretin mimetics: new age drugs for type 2 diabetes mellitus

Type 2 diabetes mellitus is a fast growing global epidemic and its prevalence has increased in the 21st century. The rise in blood glucose levels is associated with complex pathogenesis which includes a significant reduc...

Renal clearance and urinary excretion of ciprofloxacin in lohi sheep

This study was undertaken with objective to investigate the renal clearance and urinary excretion of ciprofloxacin in eight sheep of Lohi breed. Ciprofloxacin was administered at the rate of 5 mg/kg body weight intramusc...

Download PDF file
  • EP ID EP146164
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Syed Mahmood, Junaid Alam, Amna Hussain (2011). Determination of neuron specific enolase (NSE) in small cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC) patients. Pakistan Journal of Pharmacology, 28(1), 23-32. https://europub.co.uk/articles/-A-146164